TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 78 filers reported holding TRICIDA INC in Q4 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $182,000 | +8.3% | 17,336 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $168,000 | +17.5% | 17,336 | -0.6% | 0.00% | +33.3% |
| Q1 2022 | $143,000 | -19.2% | 17,449 | -5.7% | 0.00% | -25.0% |
| Q4 2021 | $177,000 | +94.5% | 18,512 | -5.1% | 0.00% | +100.0% |
| Q3 2021 | $91,000 | +8.3% | 19,512 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $84,000 | -18.4% | 19,512 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $103,000 | -29.9% | 19,512 | -6.5% | 0.00% | -25.0% |
| Q4 2020 | $147,000 | -20.1% | 20,862 | +2.5% | 0.00% | -33.3% |
| Q3 2020 | $184,000 | -53.2% | 20,344 | +42.3% | 0.01% | -57.1% |
| Q2 2020 | $393,000 | +25.2% | 14,298 | +0.1% | 0.01% | 0.0% |
| Q1 2020 | $314,000 | -30.4% | 14,278 | +19.4% | 0.01% | -22.2% |
| Q4 2019 | $451,000 | +26.3% | 11,963 | +3.4% | 0.02% | +20.0% |
| Q3 2019 | $357,000 | -3.3% | 11,572 | +23.9% | 0.02% | -6.2% |
| Q2 2019 | $369,000 | – | 9,339 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |